Sky Century Investment (SKYI) Common Equity (2013 - 2026)
Sky Century Investment's (SKYI) quarterly Common Equity came in at -$227680.0 in Q2 2026, up 8.89% year-on-year from -$209087.4 in Q2 2025, and up 26.16% on a QoQ basis from -$308333.0 in Q1 2026.
Sky Century Investment (SKYI) Common Equity (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 5 years of Common Equity data on file, last reported at -$227680.0 in Q2 2026.
- On a quarterly basis, Common Equity rose 8.89% year-over-year to -$227680.0 in Q2 2026; TTM through May 2026 was -$227680.0, a 8.89% increase from a year earlier, with the FY2025 full-year figure at -$285707.0, down 44.61% from the prior year.
- Common Equity for Q2 2026 stood at -$227680.0, up from -$308333.0 in the prior quarter.
- Over the last five years, Common Equity for SKYI reached as high as -$168816.0 in Q1 2024 and fell as low as -$313920.0 in Q4 2025.
- Historically, Common Equity has averaged -$241095.8 across 3 years, with a median of -$238029.5 in 2024.
- Across the five-year window, Common Equity slumped 44.61% in 2025 and rose 8.89% in 2026, its largest moves.
- Year by year, Common Equity stood at -$239204.0 in 2024, then tumbled by 31.24% to -$313920.0 in 2025, then grew by 27.47% to -$227680.0 in 2026.
- Per Business Quant data, the three most recent Common Equity figures were -$227680.0 in Q2 2026, -$308333.0 in Q1 2026, and -$313920.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | -227,680.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -227,680.00 |
| Feb 28, 2026 | -308,333.00 |
| Nov 30, 2025 | -313,920.00 |
| Aug 31, 2025 | -285,707.00 |
| May 31, 2025 | -249,902.00 |
| Feb 28, 2025 | -236,855.00 |
| Nov 30, 2024 | -239,204.00 |
| Aug 31, 2024 | -197,576.00 |
| May 31, 2024 | -182,965.00 |
| Feb 29, 2024 | -168,816.00 |
| Aug 31, 2014 | -40,195.00 |
| May 31, 2014 | -31,765.00 |
| Feb 28, 2014 | -26,185.00 |
| Nov 30, 2013 | -26,185.00 |
| Aug 31, 2013 | -5,350.00 |
| May 31, 2013 | -13,846.00 |